Xarelto May Protect Against Clot Problems in HF - MedPage Today

Xarelto May Protect Against Clot Problems in HF  MedPage Today

Rivaroxaban (Xarelto) was associated with a reduced risk of thromboembolic events among patients with heart failure (HF) and coronary artery disease, ...



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more